GSE128730 neratinib OVCAR-8 0 v 1 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE128730_neratinib_OVCAR-8_0_v_1_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE128730_neratinib_OVCAR-8_0_v_1_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE128730_neratinib_OVCAR-8_0_v_1_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE128730_neratinib_OVCAR-8_0_v_1_human_up.

Results found

Linked to

 

Label

Description

 

Gene

MIR4435-2 host gene

Gene

small nucleolar RNA host gene 1

Gene

small nucleolar RNA host gene 29

Gene

small nucleolar RNA host gene 5

Gene

cytoskeleton regulator RNA

Gene

Gfo/Idh/MocA-like oxidoreductase domain containing 3, pseudogene

Gene

long intergenic non-protein coding RNA 665

Gene

long intergenic non-protein coding RNA 839

Gene

zinc finger protein 542, pseudogene

Gene

CTA-216E10.6


  • Gene

    small nucleolar RNA host gene 1


  • Gene

    small nucleolar RNA host gene 29


  • Gene

    small nucleolar RNA host gene 5


  • Gene

    cytoskeleton regulator RNA


  • Gene

    Gfo/Idh/MocA-like oxidoreductase domain containing 3, pseudogene


  • Gene

    long intergenic non-protein coding RNA 665


  • Gene

    long intergenic non-protein coding RNA 839


  • Gene

    zinc finger protein 542, pseudogene


  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.